Market Overview:
The global omeprazole sodium for injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of gastrointestinal disorders, rising geriatric population, and growing demand for injectable drugs. By type, the 20mg segment is expected to account for the largest share of the global omeprazole sodium for injection market in 2018. By application, the hospital segment is expected to account for the largest share of the global omeprazole sodium for injection market in 2018.
Product Definition:
Omeprazole sodium for injection is a proton pump inhibitor. It is used to decrease the amount of acid in the stomach. This medicine is given by injection into a vein.
20mg:
20mg is used for the treatment of heartburn and indigestion. Heartburn or acid reflux occurs when the acidic content in the stomach rises to the upper gastrointestinal tract, which can damage various parts of the GI system. 20 mg Omeprazole Sodium for Injection is usually administered every four to six hours as needed to reduce symptoms.
The global market for 20mg Omeprazole Sodium for Injection was valued at USD 745 million in 2016.
40mg:
40mg is used for the treatment of heartburn and indigestion. It reduces stomach acid production and allows it to remain in the stomach longer, which delays gastric emptying time and results in a more comfortable feeling.
Omeprazole Sodium for Injection is used as an anti-reflux medication that works by decreasing or eliminating the urge to eat frequently, usually after meals.
Application Insights:
The market is categorized based on application into hospital, drug store and others. The other applications include hospitals, clinics and private practices. Among these, the drug stores held the largest share owing to increasing awareness about lifestyle diseases among general population as well as healthcare professionals.
Omeprazole sodium for injection was one of the most prescribed medicines in Europe in 2016 due to its high efficacy compared to other anti-ulcer drugs available in the market such as pantethine hydrochloride and cimetidine. In addition, growing prevalence of Helicobacter pylori infection coupled with rising number of gastric ulcers has driven demand for omeprazole sodium for injection over recent years.
In addition, manufacturers are focusing on expanding their distribution network by entering into new markets including India.
Regional Analysis:
Europe dominated the global market in 2017 owing to high product demand as a result of rising incidence of gastric cancer and ulcers. In addition, increasing number of omeprazole sodium injection manufacturing facilities in Europe is expected to drive the regional market over the forecast period. Asia Pacific is expected to witness significant growth during the forecast period due to growing geriatric population, improving economic conditions and rising awareness about lifestyle changes among people leading unhealthy lifestyles such as smoking and alcohol consumption. Moreover, increasing prevalence of diabetes is also anticipated to fuel product demand during the forecast period.
In addition, major manufacturers are expanding their presence in this region by opening distribution centers or subsidiaries for marketing purposes. For instance; Sun Pharmaceutical Industries Limited has entered into distribution agreement with Fresenius Kabi for marketing its products outside India under various brands including Prilosec OTC & Pronestyl in more than 30 countries worldwide including South Africa, Kuwait & Saudi Arabia etc.
Growth Factors:
- Increasing incidence of gastrointestinal diseases: The increasing incidence of gastrointestinal diseases is one of the key growth drivers for the Omeprazole Sodium for Injection market. This is because Omeprazole Sodium for Injection is used to treat various gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcer, and Zollinger-Ellison syndrome.
- Rising demand from emerging markets: The rising demand from emerging markets is another key growth driver for the Omeprazole Sodium for Injection market. This is because a large number of people in these regions are suffering from various gastrointestinal disorders, which can be treated with Omeprazole Sodium for Injection.
- Technological advancements: The technological advancements in the field of drug discovery and development are another key growth driver for the Omeprazole Sodium for Injection market. This is because they have enabled manufacturers to develop better formulations and dosage forms of omeprazole sodium that offer better patient compliance and efficacy profiles than earlier versions available in the marketplaces .
Scope Of The Report
Report Attributes
Report Details
Report Title
Omeprazole Sodium for Injection Market Research Report
By Type
20mg, 40mg, 60mg
By Application
Hospital, Drug Store, Other
By Companies
Changchun Fuchun Pharmaceutical, Zhejiang Conba BioPharmaceuticsl, Hozen MedAsia, Furen Pharmaceutical Group, Reyoung Pharmaceutical, Chengdu Beite Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Omeprazole Sodium for Injection Market Report Segments:
The global Omeprazole Sodium for Injection market is segmented on the basis of:
Types
20mg, 40mg, 60mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Changchun Fuchun Pharmaceutical
- Zhejiang Conba BioPharmaceuticsl
- Hozen MedAsia
- Furen Pharmaceutical Group
- Reyoung Pharmaceutical
- Chengdu Beite Pharmaceutical
Highlights of The Omeprazole Sodium for Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 20mg
- 40mg
- 60mg
- By Application:
- Hospital
- Drug Store
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Omeprazole Sodium for Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Omeprazole Sodium for Injection is a medication used to treat stomach ulcers. It is given by injection into a vein.
Some of the major companies in the omeprazole sodium for injection market are Changchun Fuchun Pharmaceutical, Zhejiang Conba BioPharmaceuticsl, Hozen MedAsia, Furen Pharmaceutical Group, Reyoung Pharmaceutical, Chengdu Beite Pharmaceutical.
The omeprazole sodium for injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Omeprazole Sodium for Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Omeprazole Sodium for Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Omeprazole Sodium for Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Omeprazole Sodium for Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Omeprazole Sodium for Injection Market Size & Forecast, 2018-2028
4.5.1 Omeprazole Sodium for Injection Market Size and Y-o-Y Growth
4.5.2 Omeprazole Sodium for Injection Market Absolute $ Opportunity
Chapter 5 Global Omeprazole Sodium for Injection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Omeprazole Sodium for Injection Market Size Forecast by Type
5.2.1 20mg
5.2.2 40mg
5.2.3 60mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Omeprazole Sodium for Injection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Omeprazole Sodium for Injection Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Omeprazole Sodium for Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Omeprazole Sodium for Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Omeprazole Sodium for Injection Analysis and Forecast
9.1 Introduction
9.2 North America Omeprazole Sodium for Injection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Omeprazole Sodium for Injection Market Size Forecast by Type
9.6.1 20mg
9.6.2 40mg
9.6.3 60mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Omeprazole Sodium for Injection Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Omeprazole Sodium for Injection Analysis and Forecast
10.1 Introduction
10.2 Europe Omeprazole Sodium for Injection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Omeprazole Sodium for Injection Market Size Forecast by Type
10.6.1 20mg
10.6.2 40mg
10.6.3 60mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Omeprazole Sodium for Injection Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Omeprazole Sodium for Injection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Omeprazole Sodium for Injection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Omeprazole Sodium for Injection Market Size Forecast by Type
11.6.1 20mg
11.6.2 40mg
11.6.3 60mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Omeprazole Sodium for Injection Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Omeprazole Sodium for Injection Analysis and Forecast
12.1 Introduction
12.2 Latin America Omeprazole Sodium for Injection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Omeprazole Sodium for Injection Market Size Forecast by Type
12.6.1 20mg
12.6.2 40mg
12.6.3 60mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Omeprazole Sodium for Injection Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Omeprazole Sodium for Injection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Omeprazole Sodium for Injection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Omeprazole Sodium for Injection Market Size Forecast by Type
13.6.1 20mg
13.6.2 40mg
13.6.3 60mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Omeprazole Sodium for Injection Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Omeprazole Sodium for Injection Market: Competitive Dashboard
14.2 Global Omeprazole Sodium for Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Changchun Fuchun Pharmaceutical
14.3.2 Zhejiang Conba BioPharmaceuticsl
14.3.3 Hozen MedAsia
14.3.4 Furen Pharmaceutical Group
14.3.5 Reyoung Pharmaceutical
14.3.6 Chengdu Beite Pharmaceutical
